Can-Fite BioPharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CANF and other ETFs, options, and stocks.

About CANF

Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602. 

CEO
Motti Farbstein
CEOMotti Farbstein
Employees
5
Employees5
Headquarters
Ramat Gan, HaMerkaz
HeadquartersRamat Gan, HaMerkaz
Founded
1994
Founded1994
Employees
5
Employees5

CANF Key Statistics

Market cap
5.96M
Market cap5.96M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
3.89M
Average volume3.89M
High today
$5.33
High today$5.33
Low today
$4.50
Low today$4.50
Open price
$4.92
Open price$4.92
Volume
880.02K
Volume880.02K
52 Week high
$46.60
52 Week high$46.60
52 Week low
$3.36
52 Week low$3.36

CANF News

TipRanks 7h
Can-Fite BioPharma Secures $4 Million via Repriced Warrant Exercise to Fund Clinical Pipeline

The latest announcement is out from Can-Fite BioPharma ( (CANF) ). On March 4, 2026, Can-Fite BioPharma entered a definitive inducement agreement with a warran...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.